1. |
Zhang B, Zhang Y, Li R, et al. The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis. J Orthop Surg Res, 2020, 15(1): 51.
|
2. |
王薇, 刘艳, 管雪红. 青少年及儿童骨肉瘤患者远期预后的影响因素. 实用癌症杂志, 2022, 37(3): 498-500.
|
3. |
朱勇, 孟翔凌, 徐阿曼, 等. 外周血免疫炎症细胞与肝细胞癌预后的关系. 肝胆外科杂志, 2019, 27(4): 275-278.
|
4. |
Chen JH, Zhai ET, Yuan YJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol, 2017, 23(34): 6261-6272.
|
5. |
Liu J, Li S, Zhang S, et al. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. J Clin Lab Anal, 2019, 33(8): e22964.
|
6. |
Cao X, Xue J, Yang H, et al. Association of clinical parameters and prognosis with the pretreatment systemic immune-inflammation index (SII) in patients with gastric cancer. J Coll Physicians Surg Pak, 2021, 31(1): 83-88.
|
7. |
Singh N, Baby D, Rajguru JP, et al. Inflammation and cancer. Ann Afr Med, 2019, 18(3): 121-126.
|
8. |
Nøst TH, Alcala K, Urbarova I, et al. Systemic inflammation markers and cancer incidence in the UK Biobank. Eur J Epidemiol, 2021, 36(8): 841-848.
|
9. |
曹琳玮. NLR、PLR、RDW 与行假体置换术的膝关节周围骨肉瘤预后的关系. 太原: 山西医科大学, 2022.
|
10. |
Tu J, Wen L, Huo Z, et al. Predictive value of dynamic change of haemoglobin levels during therapy on treatment outcomes in patients with Enneking stage IIB extremity osteosarcoma. BMC Cancer, 2018, 18(1): 428.
|
11. |
Bacci G, Forni C, Longhi A, et al. Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution. J Surg Oncol, 2007, 96(2): 118-123.
|
12. |
Folkman J. Angiogenesis: an organizing principle for drug discovery?. Nat Rev Drug Discov, 2007, 6(4): 273-286.
|
13. |
Rachidi S, Metelli A, Riesenberg B, et al. Platelets subvert T cell immunity against cancer via GARP-TGFβ axis. Sci Immunol, 2017, 2(11): eaai7911.
|
14. |
杨子波, 廖威明, 傅明, 等. 骨肉瘤患者高血小板血症与预后的相关性分析. 中华肿瘤防治杂志, 2009, 16(7): 544-546.
|
15. |
Shan ZG, Yan ZB, Peng LS, et al. Granulocyte-macrophage colony-stimulating factor-activated neutrophils express B7-H4 that correlates with gastric cancer progression and poor patient survival. J Immunol Res, 2021, 2021: 6613247.
|
16. |
Zhou WW, Chu YP, An GY. Significant difference of neutrophil-lymphocyte ratio between colorectal cancer, adenomatous polyp and healthy people. Eur Rev Med Pharmacol Sci, 2017, 21(23): 5386-5391.
|
17. |
Xiong S, Dong L, Cheng L. Neutrophils in cancer carcinogenesis and metastasis. J Hematol Oncol, 2021, 14(1): 173.
|
18. |
Paijens ST, Vledder A, de Bruyn M, et al. Tumor-infiltrating lymphocytes in the immunotherapy era. Cell Mol Immunol, 2021, 18(4): 842-859.
|
19. |
Wouters MCA, Nelson BH. Prognostic significance of tumor-infiltrating b cells and plasma cells in human cancer. Clin Cancer Res, 2018, 24(24): 6125-6135.
|